The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immunovant Inc shares valued at $51,780 were sold by Stout Jay S on Jan 22 ’25. At $23.59 per share, Stout Jay S sold 2,195 shares. The insider’s holdings dropped to 139,991 shares worth approximately $3.09 million following the completion of this transaction.
Also, Geffner Michael sold 2,657 shares, netting a total of over 62,679 in proceeds. Following the sale of shares at $23.59 each, the insider now holds 132,314 shares.
Before that, Macias William L. had sold 2,383 shares from its account. In a trade valued at $56,782, the Chief Medical Officer traded Immunovant Inc shares for $23.83 each. Upon closing the transaction, the insider’s holdings decreased to 2,383 shares, worth approximately $7.93 million.
As published in a research note from Wolfe Research on January 03, 2025, Immunovant Inc [IMVT] has been rated down from an Outperform to a Peer perform. As of October 09, 2024, Oppenheimer has reiterated its “an Outperform” rating for IMVT. Earlier on March 28, 2024, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for IMVT stock.
Analyzing IMVT Stock Performance
During the last five days, there has been a drop of approximately -5.68%. Over the course of the year, Immunovant Inc shares have dropped approximately -10.90%. Shares of the company reached a 52-week high of $25.79 on 01/02/25 and a 52-week low of $21.48 on 01/29/25. A 50-day SMA is recorded $25.61, while a 200-day SMA reached $28.16. Nevertheless, trading volume fell to 1.7 million shares from 1.41 million shares the previous day.
Support And Resistance Levels for Immunovant Inc (IMVT)
According to the 24-hour chart, there is a support level at 21.69, which, if violated, would cause prices to drop to 21.30. In the upper region, resistance lies at 22.32. The next price resistance is at 22.56. RSI (Relative Strength Index) is 33.64 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.09, which suggests the price will decrease in the coming days. Percent R is at 84.40%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
